CRA was hired by a biotech company with a new product in development for oncology. The main objective was to quantitatively understand current treatment dynamics and future market opportunity. We evaluated multiple data sources and developed patient flow and market map for two tumor types, using a patient-level claim data. We further created competitive landscape assessment and identified target intervention points for each scenario, in collaboration with the client. Research was conducted for both US and EU5 to size the global commercial opportunity.
Jeffrey Cisyk discusses recent bobblehead study in Sportico interview
In an interview with Sportico, Jeffrey Cisyk discusses how differences in stadium giveaway availability can increase ROI and promote long-term gains. Jeffrey...